Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Priority Review Vouchers: Buyers Beware!

This article was originally published in RPM Report

Executive Summary

The recent series of sales of priority review vouchers at ever-higher prices has transformed what had seemed to be a failed incentive model into a hot topic. However, one key stakeholder is not celebrating the recent developments: the FDA review teams that have to deliver the faster paced reviews continue to have strong reservations about the program.


Related Content

KaloBios Pledges To Do The Right Thing On Drug Pricing
Review Voucher Program For Rare Pediatric Diseases Should Not Be Reauthorized, FDA Says
Eye Of The Pricing Storm: FDA's Woodcock Withstands Gale-Force Rhetoric
PRVs Revisited During Drug Pricing Hearing: FDA Still Doesn’t Like Them
Picking Up The Pieces Of “Cures”: Senate Process Resets Focus On 2017
Senate Medical Innovation Bill: Will Slow, Small And Steady Win The Race?
Biopharma Quarterly Dealmaking Statistics, Q3 2015
Gilead Puts High Premium On Priority Review Voucher; Deal May Help Protect Lead In HCV
PCSK9 Meets PRV: Regeneron’s $70 Mil. Bid To Catch Up To Amgen
Treat and Trade: The New Priority Review Voucher Market


Related Companies

Related Deals

What to read next




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts